Neurocrine Biosciences
NBIX
#1478
Rank
ยฃ9.23 B
Marketcap
ยฃ92.62
Share price
-0.95%
Change (1 day)
-11.94%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : ยฃ0.88 Billion

According to Neurocrine Biosciences 's latest financial reports the company's total liabilities are ยฃ0.88 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Neurocrine Biosciences - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31ยฃ0.80 B46.47%
2022-12-31ยฃ0.54 B5.57%
2021-12-31ยฃ0.51 B15.92%
2020-12-31ยฃ0.44 B-12.51%
2019-12-31ยฃ0.51 B26.41%
2018-12-31ยฃ0.40 B22.47%
2017-12-31ยฃ0.32 B710%
2016-12-31ยฃ40.69 M19.81%
2015-12-31ยฃ33.96 M54.01%
2014-12-31ยฃ22.05 M6.16%
2013-12-31ยฃ20.77 M-19.3%
2012-12-31ยฃ25.74 M-48.89%
2011-12-31ยฃ50.36 M-37.84%
2010-12-31ยฃ81.02 M96.09%
2009-12-31ยฃ41.31 M-25.61%
2008-12-31ยฃ55.54 M-30.14%
2007-12-31ยฃ79.51 M107.76%
2006-12-31ยฃ38.26 M-29.05%
2005-12-31ยฃ53.94 M-17.41%
2004-12-31ยฃ65.31 M-28.69%
2003-12-31ยฃ91.58 M247.29%
2002-12-31ยฃ26.37 M6.34%
2001-12-31ยฃ24.79 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ยฃ0.64 B-27.90%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ6.20 B 597.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ8.42 M-99.05%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ50.75 B 5,608.00%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ103.80 B 11,573.78%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ99.95 B 11,141.63%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.67 B-24.13%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ34.51 M-96.12%๐Ÿ‡บ๐Ÿ‡ธ USA